The document discusses the prevalence of anxiety disorders, estimating a significant increase in cases by 2020, largely due to socio-economic factors and recent disasters. The Anxiety Awareness Board aims to promote awareness, recognition, and treatment options for anxiety disorders through various guidelines for both general practitioners and patients. It highlights the importance of addressing social taboos and provides a range of management strategies, including both pharmacological and non-pharmacological approaches.

1. An Overview By

2. Anxiety disorders

3. Anxiety Awareness Board – Why ? Mental Disorders makeup 5 of the 10 leading causes of disability world wide – Anxiety being one of the major shareholders Likely increase approximately 50% by 2020 Most of the conditions respond well to treatment –right approach is vital More than 90% of the patients turn up in General practitioners’ clinic initially Socio-economic situation / social taboos resulting in avoidance to seek medical advice Recent Earthquake disaster in Pakistan is likely to increase the number by thousands

4. Anxiety Awareness Board – When ?

5. Anxiety Awareness Board – the logo ? AABP The Drop and ripples represent the concept of “ increasing awareness”

6. AAB Guidelines – Aims Increase awareness regarding anxiety Recognize anxiety as a treatable disorder Diffuse the influence of social taboos in order to make the patients seek medical advice Provide easy approaches in both psychotherapeutic and pharmacological areas to General Practitioners since most of the patients turn up in their clinics

7. Red Color depicts the alarming situation of the anxiety disorders in the country Green Color represents the National Color December 2005 Anxiety Management Guidelines – the Concept White color represents relief from Anxiety

8. Anxiety Awareness Board – Core Members

9. Anxiety Awareness Board – Members

11. AAB Guidelines Highlights

12. AAB Guidelines Contents - highlights

13. AAB Guidelines – Section I (Diagnosis) Anxiety Disorders Generalized Anxiety Disorder Panic Disorder Social Phobias Obsessive Compulsive Disorder Post Traumatic Stress Disorder

14. AAB Guidelines – Section II Anxiety Disorders with co-morbidities Psychiatric Disorders such as depression or Bipolar disorders Physical disorders such as hypertension, IHD, CVAs, Diabetes, gastritis Drug induced AIDS Cancers In association with…

15. AAB Guidelines – Section III Non- Pharmacological Options for Anxiety Management Communication Skills (patient-doctor relationship) Advice on lifestyle changes Relaxation techniques Religious therapy Other techniques such as sports and meditation

16. Pharmacological Options Benzodiazepines Selective Serotinin Re-uptake Inhibitors (SSRIs) Tricyclic Antidepressants (TCAs) Serotinin Noradrenaline Selective Serotinin Reuptake Inhibitor (SNRIs) Noradrenaline Selective Serotinin Agonist (NaSSA) Beta-Blockers AAB Guidelines – Section IV Long-acting Benzodiazepines Being the Recommended Choice

17. Please do not let them become patients… Lets fight Anxiety together